ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)

NCT05081245 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Autism Spectrum Disorder

Interventions

DRUG: ML-004 (IR)/(ER) tablet
DRUG: ML-004 Placebo

Sponsor

MapLight Therapeutics